Skip to main content
Back
About Us
Our Story
Our Team
Technology + Science
Indications
Publications
Contact
Publications
Progeria
Learn More
Autosomal Dominant Polycystic Kidney Disease
Learn More
FDA Grants J&D Pharmaceuticals Rare Pediatric Disease Designation and Orphan Drug Designation
Learn More
History and Development of the Salicylates
Learn More
Molecular Mechanism of action of JD-005
Learn More
JD-004 improves TBI outcomes in the rodent model
Learn More
PC Reduces NSAID-Induced GI Toxicity
Learn More
The Role of JD-005 in TBI: Targeting Acetylated Tau
Learn More
JD-004, Placebo, and Aspirin Comparison
Learn More
JD-004 vs TYLENOL® vs ALEVE®
Learn More
Interested in learning more?
Contact Us
